论文部分内容阅读
目的:分析酮咯酸氨丁三醇+舒芬太尼和右美托咪定+舒芬太尼在胃肠道肿瘤术后镇痛中的应用效果。方法:选择我院2016年4月-2016年12月收治的50例行胃肠道肿瘤手术的患者作为本次的观察对象,分为TS组与YS组,分别在手术治疗后采取酮咯酸氨丁三醇+舒芬太尼和右美托咪定+舒芬太尼,对比两组应用效果。结果:TS组与YS组不良反应发生率分别为12.00%与4.00%,P<0.05;实验组与常规组的镇痛效果评分无明显差异,P>0.05。结论:对给予胃肠道肿瘤手术的患者选择酮咯酸氨丁三醇+舒芬太尼和右美托咪定+舒芬太尼均可达到较为显著的镇痛效果。
Objective: To analyze the effect of ketorolac tromethamine + sufentanil and dexmedetomidine + sufentanil in postoperative analgesia of gastrointestinal tumors. Methods: Fifty patients undergoing gastrointestinal cancer surgery from April 2016 to December 2016 in our hospital were selected as the observation subjects. The patients were divided into TS group and YS group. After ketorolac Trometamol + sufentanil and dexmedetomidine + sufentanil, and compared the effect of the two groups. Results: The incidence of adverse reactions in TS group and YS group was 12.00% and 4.00% respectively, P <0.05. There was no significant difference in the analgesic effect between experimental group and conventional group (P> 0.05). Conclusion: In patients given gastrointestinal cancer surgery, ketorolac tromethamine + sufentanil and dexmedetomidine + sufentanil can achieve more significant analgesic effect.